Jeena Sikho (JSLL)
Fast GrowerFairStock Score: 50/100 — MIXED
Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹521.35 |
| Market Cap | ₹6,480.42 Cr |
| P/E Ratio | 27.47 |
| ROCE | 50.24% |
| ROE | —% |
| Dividend Yield | 0.21% |
| Profit Growth | 28.4% |
| Debt/Equity | 0.27 |
| Sales Growth | 28.8% |
| Promoter Holding | 63.62% |
| 52-Week Range | ₹491.95 — ₹849.5 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹37.57 |
Strengths
- ROCE of 50.24% shows exceptional capital efficiency and a possible economic moat.
- Revenue growth of 91.6% and latest quarter net profit of ₹67 Cr on ₹222 Cr sales demonstrate strong momentum.
- Debt/Equity of 0.30 and Piotroski F-Score of 7/9 indicate a financially sound balance sheet.
- Promoter holding of 63.62% aligns management with minority shareholders.
Concerns
- P/E of 37.05 and P/B of 23.23 leave almost no margin of safety, especially with book value at only ₹28.47.
- Profit growth of 405% is likely distorted by a low base and is unsustainable over time.
- Dividend yield of 0.18% offers negligible income while waiting for reinvestment.
- ROE is reported as N/A, making it difficult to fully apply Graham's return-on-equity quality test.
AI Analysis
At first glance, Jeena Sikho looks like the kind of growth story that gets investors excited. Sales up 91.6%, profit up 405%, latest quarter ₹222 Cr sales and ₹67 Cr profit. ROCE of 50.24% is exceptional, and debt/equity of 0.30 is conservative. Piotroski F-score of 7 out of 9 tells me the underlying financials are reasonably healthy. Promoters hold 63.62%, so their interests are aligned with mine. Yet I must stop and apply the Graham test. A P/E of 37.05 and P/B of 23.23 against book value of ₹28.47 means I'm paying a steep price for every rupee of earnings and assets. The PEG of 0.15 assumes this extraordinary growth is durable; but profit growth of 405% is mathematically unsustainable. As Graham liked to say, 'The future is never clear; you pay a high price for a cheery consensus.' The dividend yield is only 0.18%, so I'm not being paid while I wait. FairStock Score of 53/100 flags a mixed picture. I would rather be late to a wonderful business at a fair price than early to an overpriced lottery ticket. If the company can keep compounding at a high rate, today's price may eventually look reasonable, but I need a margin of safety. That margin is missing at 37 times earnings. I'd put Jeena Sikho on my watchlist, but I won't chase it here.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer